logo

SMLR(Delisted)

Semler Scientific·NASDAQ
--
--(--)
1.01 / 10
Underperform

Analysis concludes inadequate fundamental quality (1.0/10). Favorable components: Cash-UP and Revenue-MV, offset by weaknesses in Net income-Revenue and Cash-MV. Investment recommendation: challenging.

Fundamental(1.01)SentimentTechnical

Analysis Checks(2/10)

Revenue-MV
Value-1.87
Score3/3
Weight-9.37%
1M Return1.60%
ROA (%)
Value4.57
Score0/3
Weight25.85%
1M Return-7.07%
Annualized return on equity (%)
Value7.39
Score1/3
Weight4.17%
1M Return-0.86%
Net cash flow from operating activities / Operating revenue (%)
Value-139.93
Score1/3
Weight11.10%
1M Return-2.36%
Net income-Revenue
Value2.36
Score1/3
Weight8.64%
1M Return-1.83%
Cash-UP
Value0.45
Score2/3
Weight15.68%
1M Return-3.45%
Annualized net profit margin on total assets (%)
Value6.10
Score0/3
Weight25.85%
1M Return-7.07%
Asset-MV
Value-0.51
Score1/3
Weight-0.91%
1M Return0.18%
ROE (%)
Value5.54
Score1/3
Weight4.17%
1M Return-0.86%
Cash-MV
Value0.42
Score0/3
Weight14.83%
1M Return-3.37%
Is SMLR undervalued or overvalued?
  • SMLR scores 1.01/10 on fundamentals and holds a Premium valuation at present. Backed by its 5.54% ROE, 130.80% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and 141.74% earnings growth, these metrics solidify its Underperform investment rating.